QIA invests in innovative healthcare company, Kardium

Doha, Qatar: Qatar Investment Authority (QIA) has invested in innovative healthcare company, Kardium Inc., the developer of the Globe Pulsed Field Sys...

Doha, Qatar: Qatar Investment Authority (QIA) has invested in innovative healthcare company, Kardium Inc., the developer of the Globe Pulsed Field System- an innovative treatment for atrial fibrillation (AF).

In a press release yesterdayday, QIA said that Kardium Inc. has raised $250m in a new financing round. QIA was joined by other new investors Janus Henderson Investors, MM Capital, Piper Heartland Healthcare Capital, Eventide Asset Management, and Eckuity Capital in leading the round. Existing investors also participated, including funds and accounts advised by T Rowe Price Associates, Inc., T. Rowe Price Investment Management, Inc., and Durable Capital Partners LP. The financing also includes an equity investment from a leading strategic investor.  

"We're thrilled to have secured this transformational financing with a world-class syndicate of investors,” said Kevin Chaplin, CEO of Kardium. "This funding enables us to move ahead with the commercial launch of the Globe System by expanding our manufacturing capabilities and building a strong commercial team. 

Everyone at Kardium is energized by the opportunity to bring the Globe System to market and help improve the lives of millions of patients worldwide suffering from atrial fibrillation." 

Impressive clinical data from the pivotal PULSAR clinical study of the Globe System demonstrates remarkable results with the Globe System, showing freedom from atrial arrhythmia at 1 year of 78 percent in paroxysmal AF patients, with 0 percent device-related primary safety events.